cprx stock price target
Analyst estimates including CPRX earnings per share estimates and analyst recommendations. Given the current short-term trend the stock is expected to fall -1222 during the next 3 months and with a 90 probability hold a price between 550 and 701 at the end of this 3-month period.
Laser Frenectomies And Tongue Ties Everyone Has A Muscle Attachment Frenum That Connects Their Lips To Their Gums However Smile Dental Dental Tourism Dental
4 analysts have issued 1-year price targets for Catalyst Pharmaceuticals shares.
. CPRX stock price news buy or sell recommendation and investing advice from Wall Street professionals. For Catalyst Pharmaceuticals stock forecast for 2025 12 predictions are offered for each month of 2025 with average Catalyst Pharmaceuticals stock forecast of 311 a high forecast of 331 and a low forecast of 293. Get the latest Catalyst Pharmaceutical Partners stock price and detailed information including CPRX news historical charts and realtime prices.
Todays 52-Week Highs. Get Catalyst Pharmaceuticals Inc CPRXNASDAQ real-time stock quotes news price and financial information from CNBC. CPRX stock forecast and price target.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. This suggests a possible upside of 634 from the stocks current price. Over the past 50 weeks CPRXs average upside potential has been 466.
CPRXs average price target has moved up 265 over the prior 29 weeks. Zacks proprietary data indicates that Catalyst Pharmaceuticals Inc. The average Catalyst Pharmaceuticals stock forecast 2023 represents a -73 decrease from the last price of 696000003814697.
CPRX Stock Trend. The average twelve-month price prediction for Catalyst Pharmaceuticals is 1092 with a high price target of 1200 and a low price target of 875. View analysts price targets for Catalyst.
Is currently rated as a Zacks Rank 3. While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. ET by Tomi Kilgore Catalyst Pharmaceuticals started at outperform with 6 stock price.
Catalyst Pharmaceuticals Incs number of analysts covering the stock is. Get the latest Catalyst Pharmaceuticals Inc. CPRX stock quote history news and other vital information to help you with your stock trading and investing.
Catalyst Pharmaceuticals Inc. Find the latest Catalyst Pharmaceuticals Inc CPRX stock price forecast 12-month price target predictions and analyst recommendations. 20 2019 at 759 am.
On average they predict Catalyst Pharmaceuticals stock price to reach 1092 in the next twelve months. Find the latest Catalyst Pharmaceuticals Inc. CPRX analyst stock forecast price target and recommendation trends with in.
US Markets Close In. Real-time trade and investing ideas on Catalyst Pharmaceuticals Inc CPRX from the largest community of traders and investors. The consensus price target hints at a 333 upside potential for Catalyst CPRX.
The average price target is 000 with a high estimate of 000 and a low estimate of 000. Catalyst Pharmaceuticals Inc 668 003 045 Watch. Rooms Shows Rankings Earnings Newsletters Shop.
Catalyst Pharmaceuticals stock price target raised to 10 from 9 at Oppenheimer Mar. CPRX stock price news historical charts analyst ratings and financial information from WSJ. Find the latest Catalyst Pharmaceuticals Inc.
5413 Upside Based on 3 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. Their forecasts range from 875 to 1200. View the latest Catalyst Pharmaceuticals Inc.
Based on analysts offering 12 month price targets for CPRX in the last 3 months. The average price target represents a 5413 change from the last price of 709. Analyst Price Target on CPRX.
5 Wall Street analysts that have issued a 1 year CPRX price target the average CPRX price target is 1160 with the highest CPRX stock price forecast at 1500 and the lowest CPRX stock price forecast at 900. The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1500 and a low estimate of 900. The Best Blue-Chip Stocks.
The average price target is 1092 with a high forecast of 1200 and a low forecast of 875. Catalyst Pharmaceuticals Inc. The Trend in the Analyst Price Target.
According to the issued ratings of 4 analysts in the last year the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX.
Laser Frenectomies And Tongue Ties Everyone Has A Muscle Attachment Frenum That Connects Their Lips To Their Gums However Smile Dental Dental Tourism Dental
Laser Frenectomies And Tongue Ties Everyone Has A Muscle Attachment Frenum That Connects Their Lips To Their Gums However Smile Dental Dental Tourism Dental
Laser Frenectomies And Tongue Ties Everyone Has A Muscle Attachment Frenum That Connects Their Lips To Their Gums However Smile Dental Dental Tourism Dental
Laser Frenectomies And Tongue Ties Everyone Has A Muscle Attachment Frenum That Connects Their Lips To Their Gums However Smile Dental Dental Tourism Dental
Laser Frenectomies And Tongue Ties Everyone Has A Muscle Attachment Frenum That Connects Their Lips To Their Gums However Smile Dental Dental Tourism Dental